Funding
You can find a number of funding opportunities and programmes below, specific for innovation, research commercialization, entrepreneurship and industry collaboration projects. Each programme has specific requirements and deadlines, and you can read much more by following the links.
If you have general questions about other funding opportunities or are seeking help for your application, please contact the Research Support team.
ACADEMIA
Grand Solutions: collaborative projects based on excellent research focused on solutions of considerable societal value.
InnoExplorer: grant to employees at public research and educational institutions and hospitals who have created a research result with commercial potential, but where the result is still at a pre-commercial stage, and where clarification or maturity is therefore required to establish whether it can be further developed in preparation for commercial or societal exploitation.
BII Faculty: collaborations with leading universities to create a unique interdisciplinary environment focused on commercialization that can foster novel ideas and lead to new spin-outs.
LF Experiment: facilitate research at Danish universities and Danish university hospitals.
Pioneer innovator Grant: stimulus fund established to accelerate commercialization of research findings and development of novel technologies within the health sciences.
Distinguished Innovator Grant: stimulate innovation and entrepreneurship by allowing for innovative researchers in Life Science to explore the commercial potential of a discovery while they remain embedded in academia.
Villum Experiment Programme: created for the special research projects that challenge the norm and have the potential to fundamentally change the way we approach important topics.
Research Grants: a series of research grants to stimulate innovative research in challenging areas of future importance.
Biopharma Speed Grant: for pre-clinical researchers in the fields of oncology, immuno-oncology, autoimmune disorders and drug discovery technologies.
Innovator Awards: support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health.
Investigator sponsored research: supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset.
General research: projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset.
Competitive grants: involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
Grants4Targets Pharmaceuticals: crowdsourcing initiative in health that offers you financial support to validate your pharmaceutical target and help test your hypothesis.
COCKPI-T: we invite researchers to submit innovative ideas related to therapeutic targets and technologies for drug discovery to gain funding to support their research financially to confirm their concepts.
EIT Health: we create an environment where the brightest minds can explore new ideas and find the practical resources to create products and services rooted in innovation.
Education: includes different calls aimed at educators who wants to bring innovation and entrepreneurship aspects into their training activities.
Research: international collaborative project proposals that demonstrates a clear innovation and address societal health challenges.
START-UP
Innofounder Graduate: accelerate the development of your innovative business idea from early stages to the stage where you are ready to go to market or gain investment.
Innobooster: grant to companies that wish to develop and make a new product or service ready for the market or to improve a process that increases the company's competitiveness and creates growth.
Grand Solutions: collaborative projects based on excellent research focused on solutions of considerable societal value.
Industrial Researcher: Business PhD and Industrial Postdoc projects.
EIC Accelerator: supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation with a market-creating potential.
Fast track to Innovation: a fully-bottom-up innovation support programme promoting close-to-the-market innovation activities open to industry-driven consortia that can be composed of all types of participants.
Eurostars: the largest international funding programme for SMEs wishing to collaborate on R&D projects that create innovative products, processes or services for commercialisation.
Innovative Medicines Initiative: EU public-private partnership funding health research and innovation.
EIT Health: we create an environment where the brightest minds can explore new ideas and find the practical resources to create products and services rooted in innovation.
Research: international collaborative project proposals that demonstrates a clear innovation and address societal health challenges.
Start-up: funding opportunities for start-ups.
Venture Lab: designed to help newly established start-ups in the early phases.
Creation House: maturation of project to attract funding.
RESEARCH COLLABORATIONS
Grønt Udviklings- og Demonstrationsprogram (GUDP) is an industrial funding program aimed at solving some of the most important challenges in the food industry and society. The challenge is to increase sustainability and solve some of the climate- and environmental problems society is facing, while also improving the economy so that the food industry can continue to create growth and employment in Denmark.
Eurostars is the only European funding programme to be specifically dedicated to support R&D-performing SMEs in their innovative R&D projects. With its bottom-up approach, it stimulates international collaborative research and innovation projects that will be rapidly commercialised. A Eurostars project must have a civilian purpose and be aimed at the development of a new product, process or service.
- Research and Innovation Actions (RIA) provide support for research- and development activities in pan-European consortia to solve societal challenges. The projects must be applied for by consortia groups, comprised of academic and non-academic institutions, i.e. universities, research institutions, hospitals, museums, NGO’s, companies, SMV’s etc. from minimum three EU-member states and/or associated member states. However, the majority of projects often includes several more project participants.
- Innovative Training Networks (ITN) support competitively selected joint research training and/or doctoral programmes, implemented by European partnerships of universities, research institutions, and non-academic organisations. ITNs can include industrial doctorates, in which non-academic organisations have an equal role to universities in respect of the researcher's time and supervision.
- Individual fellowships (IF) support experienced researchers undertaking mobility between countries, optionally to the non-academic sector.
- Research and Innovation Staff Exchange (RISE) funds short-term exchanges of personnel between academic, industrial and commercial organisations throughout the world. It helps people develop their knowledge, skills and careers, while building links between organisations working in different sectors of the economy, including universities, research institutes and SMEs
OPEN INNOVATION
The list includes a selection of programs and initiatives for partnership and collaboration with private and public institutions and access to their libraries and facilities.
Collaborative public-private partnership aiming to deliver innovative drug discovery starting points with free access to up to 550,000 novel compounds, a unique industry-standard uHTS platform, and much more.
List of high-capacity screening platforms throughout Europe, which jointly use a rationally selected compound collection, comprising up to 140.000 commercial and proprietary compounds collected from European chemists.
Collaboration with academic institutions and investigators to push forward great science, using the depth and breadth of the Pfizer enterprise to accelerate concepts into viable therapies with breakthrough potential for patients.
Free access to chemical probes for novel drug discovery targets.
Target Innovation - Access to screening facilities and compound library to test innovative targets.
CoSolve - Quarterly initiative that launches with seven ambitious challenges currently facing the company’s drug discovery and development teams. The best proposals will be selected for collaboration agreements and funded.
Free access to unique disease-relevant assays, and insight.
Free and open access to selected pre-clinical compounds for non-clinical investigation purposes.
Open Lab - Invitation for guest researchers to conduct their own research projects alongside the teams at the Merck Biopharma laboratories in Darmstadt, Germany.
Biopharma Mini Library - Free access to Mini Library, which contains former Merck Biopharma research and development compounds and their derivatives.
Open Compound Sourcing - Submission of researcher’s proprietary compounds to be included in Merck’s high throughput screening library and utilized in efforts to identify new therapeutics. In case of hits, Merck will contact the researcher to discuss the potential follow-up collaboration.
Open Global Health Library - Free access to set of research compounds for infectious diseases.